We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




High Blood Sugar Associated with Postoperative Infection

By LabMedica International staff writers
Posted on 04 Oct 2010
Elevated blood glucose levels can be a predictor of infection after surgical intervention. More...


Surgical site infection accounts for 14% - 17% of hospital-acquired infections, making it the third most common type of infection acquired at healthcare facilities and the most common among patients having surgery.

In a review of 1,561 patients at Albany Medical College, (Albany, NY, USA), blood glucose values were available for 559 who had vascular surgery, 226 who had colorectal surgery and 776 who had a type of general surgery other than colorectal. Overall, 7.4% of the patients developed surgical site infections, including 14.1% of those who had colorectal surgery, 10.3% who had vascular surgery, and 4.4% of those who had other general surgery.

The most important risk factor for surgical site infection was postoperative hyperglycemia in general and colorectal cancer surgery patients. Those with serum glucose levels higher than 110 mg/dL were associated with increasingly higher rates of postsurgical infection. A subanalysis of colorectal surgery patients found that a postoperative serum glucose level higher than 140 mg/dL was the only significant predictor of surgical site infection. Among vascular surgery patients, operative time and diabetes were the only significant predictors of surgical site infection, which was not associated with postoperative hyperglycemia. The results of the study were published in the September 2010, issue of Archives of Surgery.

The authors noted, "If hyperglycemia is confirmed in future prospective studies with better postoperative glucose data to be an independent risk factor for post surgical infection in general surgery patients, this would give surgeons a modifiable variable to reduce the incidence of postoperative infection. Hyperglycemia may impair the immune system, and insulin may have anti-inflammatory and other anti-infective activities. However, it is possible that the accumulation of other risk factors for surgical site infection causes hyperglycemia rather than vice versa; hence, further study is needed."

Related Links:

Albany Medical College



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Electrolyte Analyzer
CBS-4000 (CBS-400)
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.